Vanguard Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.09M | Sell |
2,009,145
-19,815
| -1% | -$40.3K | ﹤0.01% | 3280 |
|
2025
Q1 | $3.31M | Buy |
2,028,960
+355,372
| +21% | +$579K | ﹤0.01% | 3317 |
|
2024
Q4 | $3.06M | Sell |
1,673,588
-124,372
| -7% | -$228K | ﹤0.01% | 3439 |
|
2024
Q3 | $10.4M | Buy |
1,797,960
+216,389
| +14% | +$1.25M | ﹤0.01% | 2938 |
|
2024
Q2 | $12.8M | Sell |
1,581,571
-12,814
| -0.8% | -$104K | ﹤0.01% | 2779 |
|
2024
Q1 | $22.1M | Sell |
1,594,385
-52,787
| -3% | -$733K | ﹤0.01% | 2550 |
|
2023
Q4 | $10.1M | Sell |
1,647,172
-25,731
| -2% | -$157K | ﹤0.01% | 2943 |
|
2023
Q3 | $7.81M | Buy |
1,672,903
+579
| +0% | +$2.7K | ﹤0.01% | 3028 |
|
2023
Q2 | $8.96M | Buy |
1,672,324
+150,265
| +10% | +$805K | ﹤0.01% | 3010 |
|
2023
Q1 | $15M | Buy |
1,522,059
+101,851
| +7% | +$1M | ﹤0.01% | 2740 |
|
2022
Q4 | $26.6M | Buy |
1,420,208
+138,349
| +11% | +$2.59M | ﹤0.01% | 2489 |
|
2022
Q3 | $26.5M | Buy |
1,281,859
+167,560
| +15% | +$3.47M | ﹤0.01% | 2506 |
|
2022
Q2 | $23.1M | Buy |
1,114,299
+176,972
| +19% | +$3.67M | ﹤0.01% | 2570 |
|
2022
Q1 | $40.4M | Buy |
937,327
+17,384
| +2% | +$749K | ﹤0.01% | 2409 |
|
2021
Q4 | $55.1M | Buy |
919,943
+6,894
| +0.8% | +$413K | ﹤0.01% | 2296 |
|
2021
Q3 | $78.4M | Buy |
913,049
+689
| +0.1% | +$59.2K | ﹤0.01% | 2115 |
|
2021
Q2 | $101M | Sell |
912,360
-45,082
| -5% | -$5.01M | ﹤0.01% | 2000 |
|
2021
Q1 | $107M | Buy |
957,442
+191,972
| +25% | +$21.4M | ﹤0.01% | 1915 |
|
2020
Q4 | $81.3M | Sell |
765,470
-13,717
| -2% | -$1.46M | ﹤0.01% | 1941 |
|
2020
Q3 | $108M | Sell |
779,187
-19,587
| -2% | -$2.73M | ﹤0.01% | 1649 |
|
2020
Q2 | $258M | Buy |
798,774
+332,598
| +71% | +$108M | 0.01% | 1109 |
|
2020
Q1 | $41.6M | Buy |
466,176
+45,143
| +11% | +$4.03M | ﹤0.01% | 1960 |
|
2019
Q4 | $16.7M | Sell |
421,033
-4,970
| -1% | -$197K | ﹤0.01% | 2618 |
|
2019
Q3 | $10.5M | Buy |
426,003
+20,986
| +5% | +$516K | ﹤0.01% | 2791 |
|
2019
Q2 | $14.3M | Buy |
405,017
+2,918
| +0.7% | +$103K | ﹤0.01% | 2672 |
|
2019
Q1 | $18M | Buy |
402,099
+23,173
| +6% | +$1.04M | ﹤0.01% | 2553 |
|
2018
Q4 | $18.2M | Buy |
378,926
+25,311
| +7% | +$1.21M | ﹤0.01% | 2491 |
|
2018
Q3 | $23.6M | Buy |
353,615
+15,371
| +5% | +$1.03M | ﹤0.01% | 2507 |
|
2018
Q2 | $15.9M | Buy |
338,244
+12,509
| +4% | +$588K | ﹤0.01% | 2673 |
|
2018
Q1 | $18.4M | Buy |
325,735
+1,997
| +0.6% | +$113K | ﹤0.01% | 2533 |
|
2017
Q4 | $16M | Buy |
323,738
+8,734
| +3% | +$433K | ﹤0.01% | 2593 |
|
2017
Q3 | $24M | Buy |
315,004
+46,069
| +17% | +$3.51M | ﹤0.01% | 2402 |
|
2017
Q2 | $25.3M | Buy |
268,935
+10,764
| +4% | +$1.01M | ﹤0.01% | 2358 |
|
2017
Q1 | $20.5M | Buy |
258,171
+18,905
| +8% | +$1.5M | ﹤0.01% | 2435 |
|
2016
Q4 | $19.9M | Buy |
239,266
+4,957
| +2% | +$413K | ﹤0.01% | 2423 |
|
2016
Q3 | $26.2M | Buy |
234,309
+1,462
| +0.6% | +$164K | ﹤0.01% | 2245 |
|
2016
Q2 | $25.8M | Buy |
232,847
+9,754
| +4% | +$1.08M | ﹤0.01% | 2216 |
|
2016
Q1 | $23.3M | Buy |
223,093
+16,428
| +8% | +$1.72M | ﹤0.01% | 2233 |
|
2015
Q4 | $16.7M | Buy |
206,665
+2,833
| +1% | +$228K | ﹤0.01% | 2385 |
|
2015
Q3 | $14.1M | Buy |
203,832
+13,124
| +7% | +$910K | ﹤0.01% | 2434 |
|
2015
Q2 | $18.7M | Buy |
190,708
+22,481
| +13% | +$2.2M | ﹤0.01% | 2389 |
|
2015
Q1 | $16.5M | Buy |
168,227
+7,288
| +5% | +$714K | ﹤0.01% | 2406 |
|
2014
Q4 | $17.7M | Buy |
160,939
+15,800
| +11% | +$1.74M | ﹤0.01% | 2286 |
|
2014
Q3 | $17.2M | Buy |
145,139
+5,269
| +4% | +$623K | ﹤0.01% | 2260 |
|
2014
Q2 | $18.1M | Buy |
139,870
+21,587
| +18% | +$2.8M | ﹤0.01% | 2250 |
|
2014
Q1 | $18.9M | Buy |
118,283
+34,411
| +41% | +$5.5M | ﹤0.01% | 2210 |
|
2013
Q4 | $11.7M | Buy |
83,872
+7,151
| +9% | +$995K | ﹤0.01% | 2393 |
|
2013
Q3 | $7.62M | Buy |
76,721
+4,429
| +6% | +$440K | ﹤0.01% | 2523 |
|
2013
Q2 | $2.76M | Buy |
+72,292
| New | +$2.76M | ﹤0.01% | 2952 |
|